Auro Laboratories Q2 Results

  • BSE: 530233
  • NSE: -
  • ISIN: INE292C01011
  • Sector: Biotechnology & Drugs
BSE
207.47.80 (3.91%)
Volume6.78 K
Updated: Mon 25 Nov, 2024 | 15:46:17
NSE
This stock is not traded on NSE
Today: 203.65
209.55
52-Wk: 111.85
307.20

Q2 Results Highlights

  • Total Income
    ₹3.10 Cr.
    (-45.79%)
  • Operating Profit
    ₹0.45 Cr.
    (-56.99%)
  • Profit After Tax
    ₹0.36 Cr.
    (-52.42%)
  • Operating Margin
    14.60%
    (-28.95%)
Note: Comparison is on YoY basis

Quarterly - Auro Laboratories Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 24Jun 23QoQ CompSep 23YoY Comp
Total Revenue 3.1010.18-%13.41-%
Selling/ General/ Admin Expenses Total 1.050.84-%0.95-%
Depreciation/ Amortization 0.270.27-%0.27-%
Other Operating Expenses Total 1.272.22-%2.90-%
Total Operating Expense 2.659.30-%10.65-%
Operating Income 0.450.88-%2.76-%
Net Income Before Taxes 0.480.98-%2.73-%
Net Income 0.360.71-%1.97-%
Diluted Normalized EPS 0.571.14-%3.16-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts